PDCD1 and neoplasm: To gain further insight into the effect of anti-PD1 treatment on immune cell composition in tumor bearing mice, peripheral blood and tumors extracted from anti-PD1-and IgG-treated EMT6 tumor bearing mice were analyzed by cytometry by time of flight (CyTOF) followed by flow cytometry validation.